Roivant Sciences

ROIVNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$28.163 B

$38.99 -1.96%

Close of 21 Sept 2026

Revenue

$8.26M

#3193 by revenue

Earnings

-$299.8M

Loss-making

Shares outstanding

722,323,015

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#19Alnylam PharmaceuticalsALNY$32.7B
#20ZoetisZTS$29.5B
#21Roivant SciencesROIV$28.2B
#22InsmedINSM$26.4B
#23United TherapeuticsUTHR$21.1B

What if Roivant Sciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$41,912.07

Per share 1,075× higher

Bitcoin $1.72T

$2,380.93

Per share 61.1× higher

Nvidia $5.48T

$7,586.44

Per share 195× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Roivant Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.